Rating Change
B. Riley Securities analysts reiterated a Buy rating on Trevi Therapeutics, Inc. Common Stock (NASDAQ:TRVI) on July 20, 2026.
reiterateNASDAQ:TRVI
B. Riley Securities Reiterates Buy Rating on Trevi Therapeutics, Inc. Common Stock (TRVI)
Rating Change B. Riley Securities analysts reiterated a Buy rating on Trevi Therapeutics, Inc. Common Stock (NASDAQ:TRVI) on July 20, 2026.
Market Context
Trevi Therapeutics, Inc. Common Stock operates in the Healthcare sector. The stock currently trades at $16.77 with a market capitalization of $1.7B.
Analyst coverage from B. Riley Securities provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Trevi Therapeutics, Inc. Common Stock.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Trevi Therapeutics, Inc. Common Stock
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 20, 2026 | B. Riley Securities | Buy | N/A |
| Jul 20, 2026 | HC Wainwright & Co. | Buy | N/A |
| May 20, 2026 | Needham | Buy | N/A |
| May 06, 2026 | HC Wainwright & Co. | Buy | N/A |
| May 06, 2026 | Needham | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View TRVI Stock Page
Frequently Asked Questions
What does a Buy rating mean for TRVI?
A Buy rating from B. Riley Securities reflects the analyst's outlook on Trevi Therapeutics, Inc. Common Stock (NASDAQ:TRVI). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the TRVI forecast page.